Инструкция по применению LIVTENKITY
Содержание инструкции
LIVTENCITY 200 mg film-coated tablets
maribavir
Medicinal product subject to additional monitoring. This will allow the rapid identification of
new safety information. You can contribute by reporting any adverse effects
experienced during the use of this medicinal product. See the end of section 4 for
information on how to report adverse effects.
Read this leaflet carefully before taking this medicine as it contains
important information for you.
- Keep this leaflet. You may need to read it again.
- If you have any questions, ask your doctor, pharmacist or nurse.
- This medicine has been prescribed for you only. Do not pass it on to others, even if they have the same symptoms as you, as it may be harmful.
- If any side effects occur, including those not listed in this leaflet, tell your doctor, pharmacist or nurse. See section 4.
Contents of this leaflet
- 1. What LIVTENCITY is and what it is used for
- 2. What you need to know before you take LIVTENCITY
- 3. How to take LIVTENCITY
- 4. Possible side effects
- 5. How to store LIVTENCITY
- 6. Contents of the pack and other information
1. What is LIVTENCITY and what is it used for
LIVTENCITY is an antiviral medicine that contains the active substance maribavir.
This medicine is used to treat adults who have undergone an organ or
bone marrow transplant and have developed a cytomegalovirus (CMV) infection that has not gone away or has
reoccurred after taking another antiviral medicine.
Cytomegalovirus is a virus that is asymptomatic in many people and normally remains in the body
without causing any harm. However, if the immune system is weakened after an organ or
bone marrow transplant procedure, you may be at greater risk of developing this
infection.
2. What you need to know before you take LIVTENCITY
Do not take LIVTENCITY
- if you are allergic to the active ingredient or to any of the other ingredients of this medicine (listed in section 6)
- if you are taking any of these medicines: o ganciclovir (used to manage cytomegalovirus infection) o valganciclovir (used to manage cytomegalovirus infection)
LIVTENCITY should not be given to you if any of the above applies to you. If you are unsure, ask your doctor, pharmacist or nurse before you are given LIVTENCITY.
Warnings and precautions
Talk to your doctor or pharmacist before taking LIVTENCITY if you have previously used treatment with cyclosporine, tacrolimus, sirolimus or everolimus (medicines used to prevent transplant rejection). Further blood tests may be needed to check the levels of these medicines in your blood. High levels of these medicines could cause serious side effects.
Children and adolescents
LIVTENCITY should not be used in children and adolescents under 18 years of age, as LIVTENCITY has not been tested in this age group.
Other medicines and LIVTENCITY
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, as LIVTENCITY can affect the way other medicines work, and other medicines can affect the way LIVTENCITY works.
Your doctor or pharmacist will tell you if it is safe to take LIVTENCITY with other medicines.
There are medicines that must not be taken with LIVTENCITY. See the list under “Do not take LIVTENCITY”.
Also, tell your doctor if you are taking any of the following medicines, as your doctor may need to change your treatment or change the dose of your medicines:
- rifabutin, rifampicin - for tuberculosis (TB) or related infections
- St John's wort ( Hypericum perforatum) - a herbal medicine for depression and sleep disorders
- statins, such as atorvastatin, fluvastatin, rosuvastatin, simvastatin, pravastatin, pitavastatin
- for high cholesterol
- carbamazepine, phenobarbital, phenytoin - typically for seizures or convulsive crises (epilepsy)
- efavirenz, etravirine, nevirapine - used to treat HIV infection
- antacid (oral suspension of aluminium hydroxide and magnesium) - for heartburn or indigestion due to excess acid in the stomach
- famotidine - for heartburn or indigestion due to excess acid in the stomach
- digoxin - medicine for the heart
- clarithromycin - antibiotic
- ketoconazole and voriconazole - for fungal infections
- diltiazem - medicine for the heart
- dextromethorphan - medicine for cough
- warfarin - anticoagulant
- oral contraceptive steroids - for birth control
- midazolam - used as a sedative
You can ask your doctor, pharmacist or nurse for a list of medicines that can interact with LIVTENCITY.
Pregnancy
If you are pregnant, suspect you may be pregnant, or are planning to become pregnant, ask your doctor for advice before taking this medicine. LIVTENCITY is not recommended during pregnancy, as it has not been studied in pregnancy and it is not known whether LIVTENCITY will harm the baby during pregnancy.
Breast-feeding
If you are breast-feeding or planning to breast-feed, tell your doctor before taking this medicine.
Breast-feeding is not recommended during treatment with LIVTENCITY, as it is not known whether LIVTENCITY can pass into breast milk or have effects on the baby.
Driving and using machines
LIVTENCITY does not affect the ability to drive or operate machinery.
LIVTENCITY contains sodium
This medicine contains less than 1 mmol (23 mg) of sodium per dose, that is to say essentially “sodium-free”.
3. How to take LIVTENCITY
Take this medicine following exactly the instructions of your doctor, pharmacist or
nurse. If you have any doubts, ask your doctor, pharmacist or nurse.
The recommended dose is 400 mg twice a day. This means you must take two tablets
of LIVTENCITY 200 mg in the morning and another two 200 mg tablets in the evening. You can take this
medicine independently of meals, as a whole tablet or crushed.
If you take more LIVTENCITY than you should
If you take an excessive dose of LIVTENCITY, inform your doctor immediately.
If you forget to take LIVTENCITY
If you forget to take a dose and less than 3 hours remain until the next dose, skip
the forgotten dose and continue with the regular schedule. Do not take a double dose
to make up for the missed dose.
If you stop taking LIVTENCITY
Even if you feel better, do not stop taking LIVTENCITY without first talking
to your doctor. Taking LIVTENCITY as recommended should offer you the best
chance of eliminating the cytomegalovirus infection and/or disease.
If you have further questions about the use of this medicine, ask your doctor, pharmacist or
nurse.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Tell your doctor, pharmacist or nurse if you notice any of the following side effects:
Very common(may affect more than 1 in 10 people):
- changes in the taste of foods
- nausea
- diarrhoea
- vomiting
- fatigue
Common(may affect up to 1 in 10 people):
- increased blood levels of medicines used to prevent transplant rejection
- stomach pain (abdominal pain)
- loss of appetite
- headache
- weight loss
Reporting of side effects
If you get any side effect, talk to your doctor, pharmacist, or nurse. You can also report side effects directly
through the national reporting system listed in Annex V. By reporting side effects you can help
provide more information on the safety of this medicine.
5. How to store LIVTENCITY
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the package and on the
vial label after Exp. The expiry date refers to the last day of that month.
Do not store at a temperature above 30 °C.
Do not dispose of any medicine in waste water or household waste. Ask your pharmacist how to
dispose of medicines you no longer use. This will help protect the environment.
6. Package contents and other information
What LIVTENCITY contains
- The active ingredient is maribavir. Each film-coated tablet contains 200 mg of maribavir
- The other ingredients (excipients) are
- Tablet core:
- Microcrystalline cellulose (E460(i)), sodium starch glycolate (see section 2), magnesium stearate (E470b)
- Film coating:
- Polyvinyl alcohol (E1203), macrogol (i.e. polyethylene glycol) (E1521), titanium dioxide (E171), talc (E553b), brilliant blue FCF aluminium lake (EU) (E133)
Description of the appearance of LIVTENCITY and package contents
LIVTENCITY 200 mg film-coated tablets are blue, oval-shaped and convex with “SHP” imprinted on one side and “620” on the other side.
The tablets are packaged in high-density polyethylene (HDPE) bottles with a child-resistant closure and contain 28, 56 or 112 (2 bottles of 56) film-coated tablets.
Not all pack sizes may be marketed.
Marketing Authorisation Holder
Takeda Pharmaceuticals International AG Ireland Branch
Block 2 Miesian Plaza
50-58 Baggot Street Lower
Dublin 2
D02 HW68
Ireland
Manufacturer
Takeda Ireland Limited
Bray Business Park
Kilruddery
Co. Wicklow
Ireland
For further information on this medicinal product, contact the local representative of the Marketing Authorisation Holder:
België/Belgique/Belgien
Takeda Belgium NV
Tél/Tel: +32 2 464 06 11
[email protected]
Lietuva
Takeda, UAB
Tel: +370 521 09 070
[email protected]
България
Такеда България ЕООД
Тел.: +359 2 958 27 36
[email protected]
Luxembourg/Luxemburg
Takeda Belgium NV
Tél/Tel: +32 2 464 06 11
[email protected]
Česká republika
Takeda Pharmaceuticals Czech Republic s.r.o.
Tel: + 420 234 722 722
[email protected]
Magyarország
Takeda Pharma Kft.
Tel.: +36 1 270 7030
[email protected]
Danmark
Takeda Pharma A/S
Tlf: +45 46 77 10 10
[email protected]
Malta
Τakeda HELLAS S.A.
Tel: +30 210 6387800
[email protected]
Deutschland
Takeda GmbH
Tel: +49 (0)800 825 3325
[email protected]
Nederland
Takeda Nederland B.V.
Tel: +31 20 203 5492
[email protected]
Eesti
Takeda Pharma AS
Tel: +372 6177 669
[email protected]
Norge
Takeda AS
Tlf: +47 800 800 30
[email protected]
Ελλάδα
Τakeda ΕΛΛΑΣ Α.Ε.
Tηλ: +30 210 6387800
[email protected]
Österreich
Takeda Pharma Ges.m.b.H.
Tel: +43 (0) 800-20 80 50
[email protected]
España
Takeda Farmacéutica España S.A.
Tel: +34 917 90 42 22
[email protected]
Polska
Takeda Pharma Sp. z o.o.
Tel.: +48223062447
[email protected]
France
Takeda France SAS
Tél: + 33 1 40 67 33 00
[email protected]
Portugal
Takeda Farmacêuticos Portugal, Lda.
Tel: + 351 21 120 1457
[email protected]
Hrvatska
Takeda Pharmaceuticals Croatia d.o.o.
Tel: +385 1 377 88 96
[email protected]
România
Takeda Pharmaceuticals SRL
Tel: +40 21 335 03 91
[email protected]
Ireland
Takeda Products Ireland Ltd
Tel: 1800 937 970
[email protected]
Slovenija
Takeda Pharmaceuticals farmacevtska družba d.o.o.
Tel: + 386 (0) 59 082 480
[email protected]
Ísland
Vistor hf.
Sími: +354 535 7000
[email protected]
Slovenská republika
Takeda Pharmaceuticals Slovakia s.r.o.
Tel: +421 (2) 20 602 600
[email protected]
Italia
Takeda Italia S.p.A.
Tel: +39 06 502601
[email protected]
Suomi/Finland
Takeda Oy
Puh/Tel: 0800 774 051
[email protected]
Κύπρος
Τakeda ΕΛΛΑΣ Α.Ε.
Τηλ.: +30 210 6387800
[email protected]
Sverige
Takeda Pharma AB
Tel: 020 795 079
[email protected]
Latvija
Takeda Latvia SIA
Tel: +371 67840082
[email protected]
United Kingdom (Northern Ireland)
Takeda UK Ltd
Tel: +44 (0) 2830 640 902
[email protected]
Other sources of information
More detailed information on this medicinal product is available on the website of the European Medicines Agency, http://www.ema.europa.eu .

- Страна регистрации
- Форма выпускаFilm-coated tablet, 200 mg
- Код АТХJ05AX10
- Действующее вещество
- Отпускается по рецептуДа
- Производитель
- Информация на этой странице носит справочный характер и не является медицинской консультацией. Перед началом приема лекарства обязательно проконсультируйтесь с врачом.
- Аналоги LIVTENKITYФорма выпуска: Film-coated tablet, 150 MGДействующее вещество: МаравирокПроизводитель: VIIV HEALTHCARE BVОтпускается по рецептуФорма выпуска: Powder and solvent for injectable solution, 90MG/MLДействующее вещество: enfuvirtideПроизводитель: ROCHE REGISTRATION GMBHОтпускается по рецептуФорма выпуска: Powder for injectable solution, 2 MGДействующее вещество: bulevirtideПроизводитель: GILEAD SCIENCES IRELAND UCОтпускается по рецепту
Аналоги LIVTENKITY в других странах
Лекарства с тем же действующим веществом, доступные в других странах.
Аналог LIVTENKITY в Испания
Аналог LIVTENKITY в Украина
Врачи онлайн по LIVTENKITY
Обсудите применение LIVTENKITY и возможные следующие шаги — по оценке врача.
Получите рецепт на LIVTENKITY онлайн
Заполните форму за 2 минуты
Расскажите о симптомах, истории болезни и нужном препарате.
Выберите врача или мы назначим
Выберите специалиста или мы подберём ближайшего доступного врача.
Врач рассматривает ваш случай
Обычно в течение 30 минут. Может задать уточняющие вопросы в чате.
Получите в любой аптеке
Электронный рецепт отправляется на вашу почту — действителен по всей Польше.
Часто задаваемые вопросы
LIVTENKITY требует рецепта в Италия. Вы можете уточнить у врача онлайн, подходит ли это лекарство для вашей ситуации.
Действующее вещество LIVTENKITY — Марибавир. Эта информация помогает определить лекарства с тем же составом под другими торговыми названиями.
LIVTENKITY производится компанией TAKEDA PHARMACEUTICALS INTERNATIONAL AG IRELAND BRANCH. Упаковка и торговое название могут отличаться в зависимости от дистрибьютора.
Врачи, включая Семейные врачи, Психиатры, Дерматологи, Кардиологи, Эндокринологи, Гастроэнтерологи, Пульмонологи, Нефрологи, Ревматологи, Гематологи, Инфекционисты, Аллергологи, Гериатры, Педиатры, Онкологи, могут оценить целесообразность применения LIVTENKITY с учетом вашей ситуации и местных правил. Вы можете записаться на онлайн-консультацию, чтобы обсудить возможные варианты.
Польша имеет хорошо развитую систему здравоохранения в крупных городах, таких как Варшава, Краков, Вроцлав и Гданьск. Аптеки широко доступны и работают в соответствии с действующим законодательством, обеспечивая доступ к рецептурным препаратам.
Вы можете купить LIVTENKITY в Варшаве, Кракове, Вроцлаве или Гданьске в любой аптеке при наличии действующего рецепта.
Чтобы получить рецепт, вы можете воспользоваться Oladoctor:
Другие лекарства с тем же действующим веществом (Марибавир) включают KELSENTRI, FUTSEON, EPKLUDEX. Они могут отличаться торговым названием или формой выпуска, но содержат одинаковый терапевтический компонент. Перед изменением лечения рекомендуется проконсультироваться с врачом.
















